Abstract

HIV-1 replication is efficiently controlled by the regulator protein Tat (101 amino acids) and codified by two exons, although the first exon (1-72 amino acids) is sufficient for this process. Tat can be released to the extracellular medium, acting as a soluble pro-apoptotic factor in neighboring cells. However, HIV-1-infected CD4(+) T lymphocytes show a higher resistance to apoptosis. We observed that the intracellular expression of Tat delayed FasL-mediated apoptosis in both peripheral blood lymphocytes and Jurkat cells, as it is an essential pathway to control T cell homeostasis during immune activation. Jurkat-Tat cells showed impairment in the activation of caspase-8, deficient release of mitochondrial cytochrome c, and delayed activation of both caspase-9 and -3. This protection was due to a profound deregulation of proteins that stabilized the mitochondrial membrane integrity, such as heat shock proteins, prohibitin, or nucleophosmin, as well as to the up-regulation of NF-κB-dependent anti-apoptotic proteins, such as BCL2, c-FLIPS, XIAP, and C-IAP2. These effects were observed in Jurkat expressing full-length Tat (Jurkat-Tat101) but not in Jurkat expressing the first exon of Tat (Jurkat-Tat72), proving that the second exon, and particularly the NF-κB-related motif ESKKKVE, was necessary for Tat-mediated protection against FasL apoptosis. Accordingly, the protection exerted by Tat was independent of its function as a regulator of both viral transcription and elongation. Moreover, these data proved that HIV-1 could have developed strategies to delay FasL-mediated apoptosis in infected CD4(+) T lymphocytes through the expression of Tat, thus favoring the persistent replication of HIV-1 in infected T cells.

Highlights

  • HIV-infected T cells are quite resistant to apoptosis

  • Apoptosis Induced by factor receptor superfamily member 6 (Fas) ligand (FasL) Is Delayed in PBLs Transiently Transfected with Tat101 Alone or in the Context of human immunodeficiency virus type 1 (HIV-1) Genome—PBLs from healthy donors were transfected with pCMV-Tat101 or pCMV-Tat72 expression vectors

  • To evaluate whether the resistance to apoptosis occurred mainly on CD4ϩ T cells, the transfected PBLs challenged with FasL for 18 h were stained with an antibody against CD4 conjugated with phycoerythrin (PE) and analyzed by flow cytometry

Read more

Summary

Background

HIV-infected T cells are quite resistant to apoptosis. Results: Intracellular expression of HIV-1 Tat in T cells stabilized the mitochondrial membrane and reduced caspase activation mainly through NF-␬B activation. Our group demonstrated previously that intracellular Tat profoundly deregulates cellular gene expression, modifying the expression of genes involved in apoptosis [23] This deregulation was mainly due to the presence of the second exon, proving that the first exon is sufficient for activating viral replication, full-length Tat should exert further control on HIV-1 pathogenesis by protecting the host cells against apoptosis. The mechanism of protection was based on the following: first on the deregulation of several NF-␬B-dependent proteins, including the overexpression of BCL2 and c-FLIPS, and second on the preservation of the mitochondrial outer membrane integrity by several anti-apoptotic factors, delaying the release of cytochrome c and subsequent activation of caspase-9 and caspase-3. Getting further insight on this mechanism of protection against apoptosis in CD4ϩ T cells mediated by intracellular full-length Tat would provide a better understanding of the role of Tat in the ability of HIV-1 to create a persistent infection in the host

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call